World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

RECENT ADVANCEMENT IN THE MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION (STEMI)

Amala Boban*, Bincy T. Abraham, Dr. K. Krishnakumar, Lincy George and Jibin K. Joy

ABSTRACT

Heart Attack or Myocardial Infarction is a medical emergency caused by the blockage of blood flow to the heart. Without sufficient blood flow, the myocardial cells become deprived of oxygen and get infarcted and eventually death of myocardial cells occurs. Later it can lead to heart failure and life threatening condition. ST- elevation myocardial infarction (STEMI) is more dangerous than Non ST-elevation myocardial infarction as it is caused by complete occlusion of coronary artery. Therefore the management of STEMI is very important. The treatment procedure includes Fibrinolysis, Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG) and these primary preventive methods followed by secondary preventive methods.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR